176 related articles for article (PubMed ID: 38625699)
1. Hypertension, Cardiovascular Risk Factors, and Uterine Fibroid Diagnosis in Midlife.
Mitro SD; Wise LA; Waetjen LE; Lee C; Zaritsky E; Harlow SD; Solomon DH; Thurston RC; El Khoudary SR; Santoro N; Hedderson MM
JAMA Netw Open; 2024 Apr; 7(4):e246832. PubMed ID: 38625699
[TBL] [Abstract][Full Text] [Related]
2. Family History and Uterine Fibroid Development in Black and African American Women.
Langton CR; Harmon QE; Baird DD
JAMA Netw Open; 2024 Apr; 7(4):e244185. PubMed ID: 38568693
[TBL] [Abstract][Full Text] [Related]
3. Uterine fibroids and cardiovascular risk.
Uimari O; Auvinen J; Jokelainen J; Puukka K; Ruokonen A; Järvelin MR; Piltonen T; Keinänen-Kiukaanniemi S; Zondervan K; Järvelä I; Ryynänen M; Martikainen H
Hum Reprod; 2016 Dec; 31(12):2689-2703. PubMed ID: 27733532
[TBL] [Abstract][Full Text] [Related]
4. A single baseline ultrasound assessment of fibroid presence and size is strongly predictive of future uterine procedure: 8-year follow-up of randomly sampled premenopausal women aged 35-49 years.
Baird DD; Saldana TM; Shore DL; Hill MC; Schectman JM
Hum Reprod; 2015 Dec; 30(12):2936-44. PubMed ID: 26409013
[TBL] [Abstract][Full Text] [Related]
5. Soy-Based Infant Formula Feeding and Uterine Fibroid Development in a Prospective Ultrasound Study of Black/African-American Women.
Langton CR; Harmon QE; Upson K; Baird DD
Environ Health Perspect; 2023 Jan; 131(1):17006. PubMed ID: 36696103
[TBL] [Abstract][Full Text] [Related]
6. Circulating Sex Hormones and Risk of Uterine Fibroids: Study of Women's Health Across the Nation (SWAN).
Wong JY; Gold EB; Johnson WO; Lee JS
J Clin Endocrinol Metab; 2016 Jan; 101(1):123-30. PubMed ID: 26670127
[TBL] [Abstract][Full Text] [Related]
7. Environmental tobacco smoke and risk of late-diagnosis incident fibroids in the Study of Women's Health across the Nation (SWAN).
Wong JY; Chang PY; Gold EB; Johnson WO; Lee JS
Fertil Steril; 2016 Oct; 106(5):1157-1164. PubMed ID: 27445196
[TBL] [Abstract][Full Text] [Related]
8. Association of genital talc and douche use in early adolescence or adulthood with uterine fibroids diagnoses.
Ogunsina K; Sandler DP; Murphy JD; Harmon QE; D'Aloisio AA; Baird DD; O'Brien KM
Am J Obstet Gynecol; 2023 Dec; 229(6):665.e1-665.e10. PubMed ID: 37598998
[TBL] [Abstract][Full Text] [Related]
9. Uterine fibroid incidence and growth in an ultrasound-based, prospective study of young African Americans.
Baird DD; Patchel SA; Saldana TM; Umbach DM; Cooper T; Wegienka G; Harmon QE
Am J Obstet Gynecol; 2020 Sep; 223(3):402.e1-402.e18. PubMed ID: 32105679
[TBL] [Abstract][Full Text] [Related]
10. A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study.
Hirst A; Dutton S; Wu O; Briggs A; Edwards C; Waldenmaier L; Maresh M; Nicholson A; McPherson K
Health Technol Assess; 2008 Mar; 12(5):1-248, iii. PubMed ID: 18331704
[TBL] [Abstract][Full Text] [Related]
11. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
Murji A; Whitaker L; Chow TL; Sobel ML
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
[TBL] [Abstract][Full Text] [Related]
14. Study Selection Bias and Racial or Ethnic Disparities in Estimated Age at Onset of Cardiometabolic Disease Among Midlife Women in the US.
Reeves A; Elliott MR; Lewis TT; Karvonen-Gutierrez CA; Herman WH; Harlow SD
JAMA Netw Open; 2022 Nov; 5(11):e2240665. PubMed ID: 36342714
[TBL] [Abstract][Full Text] [Related]
15. Natural history of fibroids in pregnancy: National Institute of Child Health and Human Development Fetal Growth Studies - Singletons cohort.
Mitro SD; Peddada S; Chen Z; Buck Louis GM; Gleason JL; Zhang C; Grantz KL
Fertil Steril; 2022 Oct; 118(4):656-665. PubMed ID: 35981916
[TBL] [Abstract][Full Text] [Related]
16. Beta blockers reduce uterine fibroid incidence in hypertensive women.
Fischer NM; Nieuwenhuis TO; Hazimeh D; Voegtline K; Singh B; Segars JH
Eur J Obstet Gynecol Reprod Biol; 2023 Aug; 287():119-125. PubMed ID: 37307764
[TBL] [Abstract][Full Text] [Related]
17. Early-life exposures and early-onset uterine leiomyomata in black women in the Sister Study.
D'Aloisio AA; Baird DD; DeRoo LA; Sandler DP
Environ Health Perspect; 2012 Mar; 120(3):406-12. PubMed ID: 22049383
[TBL] [Abstract][Full Text] [Related]
18. Douching or Perineal Talc Use and Prevalent Fibroids in Young African American Women.
Wright MA; Moore KR; Upson K; Baird DD; Chin HB
J Womens Health (Larchmt); 2021 Dec; 30(12):1729-1735. PubMed ID: 33667128
[No Abstract] [Full Text] [Related]
19. Relationship between a uterine fibroid diagnosis and the risk of adverse obstetrical outcomes: a cohort study.
Karlsen K; Schiøler Kesmodel U; Mogensen O; Humaidan P; Ravn P
BMJ Open; 2020 Feb; 10(2):e032104. PubMed ID: 32071172
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D and uterine fibroid growth, incidence, and loss: a prospective ultrasound study.
Harmon QE; Patchel SA; Denslow S; LaPorte F; Cooper T; Wise LA; Wegienka G; Baird DD
Fertil Steril; 2022 Dec; 118(6):1127-1136. PubMed ID: 36150919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
